![Charlotte Hepburn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 95 893 $ in data 31/07/2026
Charlotte Moore Hepburn currently works at ZYUS Life Sciences Corp., as Independent Director from 2023.
Dr. Hepburn also formerly worked at Phoenix Canada Oil Co. Ltd., as Chairman & Chief Executive Officer from 2015 to 2023.
Dr. Hepburn received her graduate degree from Harvard University, undergraduate degree from Princeton University, and undergraduate degree from The Johns Hopkins University School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/12/2025 | 2.397.317 ( 2,98% ) | 95 893 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ZYUS LIFE SCIENCES CORPORATION | Direttore/Membro del Consiglio | 15/08/2015 |
| Società | Posizione | Fine |
|---|---|---|
| ZYUS LIFE SCIENCES CORPORATION | Amministratore Delegato | 01/01/2023 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Phoenix Canada Oil Co. Ltd.
 Phoenix Canada Oil Co. Ltd. Oil & Gas ProductionEnergy Minerals Engages in the development, production, leases and maintenance of oil and natural gas properties | Energy Minerals |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ZYUS Life Sciences Corp.
 ZYUS Life Sciences Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes cannabinoid-based pharmaceutical drug product candidates and therapeutics | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
